{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:18:06Z","timestamp":1792459086184,"version":"4.5.0"},"reference-count":735,"publisher":"Oxford University Press (OUP)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,21]]},"DOI":"10.1093\/eurheartj\/eht151","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T23:28:19Z","timestamp":1371252499000},"page":"2159-2219","source":"Crossref","is-referenced-by-count":3688,"title":["2013 ESH\/ESC Guidelines for the management of arterial hypertension"],"prefix":"10.1093","volume":"34","author":[{"name":"Authors\/Task Force Members","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Narkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Redon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zanchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Christiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Cifkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dominiczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Galderisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiny","family":"Jaarsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre E.","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios J.","family":"Manolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E.","family":"Schmieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Anton","family":"Sirnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sleight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Viigimaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Waeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESH Scientific Council","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Redon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dominiczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Narkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Viigimaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Ambrosioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Caufield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Hecht","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E.","family":"Schmieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"van de Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Committee for Practice Guidelines (CPG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christi","family":"Deaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cetin","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hasdai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno W.","family":"Hoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Nihoyannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo F.","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Anton","family":"Sirnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Tamargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tendera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Document Reviewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis L.","family":"Clement","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Coca","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry C.","family":"Gillebert","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tendera","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Agabiti","family":"Rosei","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Ambrosioni","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana Brguljan","family":"Hitij","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Caulfield","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"De Buyzere","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"De Geest","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve Anne","family":"Derumeaux","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Erdine","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Farsang","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vjekoslav","family":"Gerc","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Germano","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gielen","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Haller","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno W.","family":"Hoes","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Jordan","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kahan","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Komajda","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Lovic","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Mahrholdt","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Hecht","family":"Olsen","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ostergren","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Perk","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Polonia","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A.","family":"Popescu","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Sirenko","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Stanton","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Struijker-Boudier","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"van de Borne","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Vlachopoulos","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wood","sequence":"additional","affiliation":[{"name":"The affiliations of the Task Force Members are listed in the Appendix. The disclosure forms of the authors and reviewers are available on the respective society websites http:\/\/www.eshonline.org and www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,6,14]]},"reference":[{"key":"2026080919364782900_EHT151C1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension","volume":"21","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C2","first-page":"1105","article-title":"Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens 2007"},{"key":"2026080919364782900_EHT151C3","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/eurjhf\/hfp141","article-title":"Normal systolic blood pressure and risk of heart failure in US male physicians","volume":"11","author":"Britton","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026080919364782900_EHT151C5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ki.2009.439","article-title":"Prehypertension: is it relevant for nephrologists?","volume":"77","author":"Kalaitzidis","year":"2010","journal-title":"Kidney Int"},{"key":"2026080919364782900_EHT151C6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00004872-200304000-00013","article-title":"Blood pressure and cardiovascular disease in the Asia Pacific region","volume":"21","author":"Asia Pacific Cohort Studies Collaboration","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.amjhyper.2006.08.004","article-title":"Blood pressure parameters and risk of fatal stroke, NHANES II mortality study","volume":"20","author":"Brown","year":"2007","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","article-title":"Haemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study","volume":"96","author":"Franklin","year":"1997","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.112.201400","article-title":"Impact of Age on the Importance of Systolic and Diastolic Blood Pressures for Stroke Risk: The MOnica, Risk, Genetics, Archiving and Monograph (MORGAM) Project","volume":"60","author":"Vishram","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.HYP.30.6.1410","article-title":"Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population","volume":"30","author":"Benetos","year":"1997","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.1981.03310370017013","article-title":"Systolic blood pressure arterial rigidity risk of stroke. The Framingham study","volume":"245","author":"Kannel","year":"1981","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C12","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0895-7061(99)00252-6","article-title":"Risk stratification in hypertension: new insights from the Framingham Study","volume":"13","author":"Kannel","year":"2000","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.HYP.37.5.1256","article-title":"Cardiovascular mortality in hypertensive men according to presence of associated risk factors","volume":"37","author":"Thomas","year":"2001","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9343(72)90049-6","article-title":"Hypertension. Definitions, natural histories and consequences","volume":"52","author":"Pickering","year":"1972","journal-title":"Am J Med"},{"key":"2026080919364782900_EHT151C15","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/HJH.0b013e32832f4f6b","article-title":"Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension","volume":"27","author":"Lurbe","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/HJH.0b013e3283282f65","article-title":"Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries","volume":"27","author":"Pereira","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/HJR.0b013e32831e9511","article-title":"Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study","volume":"16","author":"Danon-Hersch","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026080919364782900_EHT151C18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1097\/01.hjh.0000176789.89505.59","article-title":"Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in","volume":"23","author":"Altun","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2524.2002.00379.x","article-title":"Distribution of blood pressures in Gemlik District, north-west Turkey","volume":"10","author":"Tugay Aytekin","year":"2002","journal-title":"Health Soc Care Community"},{"key":"2026080919364782900_EHT151C20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjhyper.2005.07.011","article-title":"Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study","volume":"19","author":"Efstratopoulos","year":"2006","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C21","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.hjh.0000179908.51187.de","article-title":"Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study","volume":"23","author":"Macedo","year":"2005","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ije\/dyh249","article-title":"Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study","volume":"33","author":"Psaltopoulou","year":"2004","journal-title":"Int J Epidemiol"},{"key":"2026080919364782900_EHT151C23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.jhh.1001724","article-title":"Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study","volume":"18","author":"Sarafidis","year":"2004","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C24","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00004872-200308000-00011","article-title":"Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the Attica study","volume":"21","author":"Panagiotakos","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.112.193078","article-title":"Achievement of cardiometabolic targets in aware hypertensive patients in Spain: a nationwide population-based study","volume":"60","author":"Banegas","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/01.hjh.0000226210.95936.bc","article-title":"Improvement in hypertension management in England: results from the Health Survey for England","volume":"24","author":"Primatesta","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.hjh.0000200508.10324.8e","article-title":"Regional disparities of hypertension prevalence and management within Germany","volume":"24","author":"Meisinger","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C28","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.hjh.0000249693.73618.c9","article-title":"Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: The Amsterdam Health Monitor Survey","volume":"24","author":"Agyemang","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C29","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/01.hjh.0000186835.63996.d4","article-title":"Prevalence, awareness, treatment and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study","volume":"23","author":"Agyemang","year":"2005","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.jhh.1002123","article-title":"Awareness, treatment and control of hypertension: the 'rule of halves' in an era of risk-based treatment of hypertension","volume":"21","author":"Scheltens","year":"2007","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.jhh.1001739","article-title":"Arterial hypertension in Poland in 2002","volume":"18","author":"Zdrojewski","year":"2004","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.jhh.1001686","article-title":"Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997\/1998 and 2000\/2001, Czech Post-MONICA Study","volume":"18","author":"Cifkova","year":"2004","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.numecd.2008.11.004","article-title":"Age- and gender-specific awareness, treatment and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study","volume":"19","author":"Scuteri","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026080919364782900_EHT151C34","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1097\/HJH.0b013e32832c41cd","article-title":"Prevalence, awareness and treatment of hypertension in Finland during 1982\u20132007","volume":"27","author":"Kastarinen","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/HYPERTENSIONAHA.108.125617","article-title":"Continued improvement in hypertension management in England: results from the Health Survey for England 2006","volume":"53","author":"Falaschetti","year":"2009","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/pubmed\/fdn078","article-title":"Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study","volume":"31","author":"Erem","year":"2009","journal-title":"J Public Health (Oxf)"},{"key":"2026080919364782900_EHT151C37","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/HJH.0b013e328311ce04","article-title":"Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction: the impact of migration as a model of gene-environment interaction project","volume":"26","author":"Costanzo","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.HYP.0000259106.77783.f8","article-title":"Using public health indicators to measure the success of hypertension control","volume":"49","author":"Cooper","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C39","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States","volume":"289","author":"Wolf-Maier","year":"2003","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C40","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/ehr045","article-title":"Stroke mortality trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure","volume":"32","author":"Redon","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C41","first-page":"1300","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension","volume":"15","author":"Pyorala","year":"1994","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/hrt.2006.108167","article-title":"Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)","volume":"93","author":"Woodward","year":"2007","journal-title":"Heart"},{"key":"2026080919364782900_EHT151C45","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"issue":"2243\u20132251, 2244p following 2251","key":"2026080919364782900_EHT151C47","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C49","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.07.020","article-title":"Value and limitations of existing scores for the assessment of cardiovascular risk: a review for physicians","volume":"54","author":"Cooney","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C50","first-page":"1635","volume":"33","author":"Perk","journal-title":"Eur Heart J 2012"},{"key":"2026080919364782900_EHT151C51","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/eurheartj\/ehp546","article-title":"Risk prediction is improved by adding markers of subclinical organ damage to SCORE","volume":"31","author":"Sehestedt","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C52","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/HJH.0b013e328356c579","article-title":"Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH\/ESC risk charts","volume":"30","author":"Sehestedt","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C53","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/HJH.0b013e3283525715","article-title":"Cardiovascular risk assessment beyond systemic coronary risk estimation: a role for organ damage markers","volume":"30","author":"Volpe","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C54","first-page":"151","article-title":"1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension","volume":"17","author":"Guidelines Subcommittee","year":"1999","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C55","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","article-title":"World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension","volume":"21","author":"World Health Organization, International Society of Hypertension Writing Group","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.322.7285.531","article-title":"Blood pressure measuring devices: recommendations of the European Society of Hypertension","volume":"322","author":"O'Brien","year":"2001","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)61710-8","article-title":"Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis","volume":"379","author":"Clark","year":"2012","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","article-title":"Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project)","volume":"31","author":"Fedorowski","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/HYPERTENSIONAHA.110.151654","article-title":"Orthostatic hypotension is a more robust predictor of cardiovascular events than night-time reverse dipping in elderly","volume":"56","author":"Fagard","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004872-199102000-00003","article-title":"Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment","volume":"9","author":"Trazzi","year":"1991","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.109.141879","article-title":"Measurement of blood pressure in the office: recognizing the problem and proposing the solution","volume":"55","author":"Myers","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C62","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjcard.2011.10.025","article-title":"Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension","volume":"109","author":"Julius","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080919364782900_EHT151C63","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.HYP.33.1.44","article-title":"Influence of heart rate on mortality in a French population: role of age, gender and blood pressure","volume":"33","author":"Benetos","year":"1999","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C64","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","article-title":"Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement","volume":"23","author":"O'Brien","year":"2005","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C65","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring","author":"O'Brien","year":"2013","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C66","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/jhh.2010.54","article-title":"European Society of Hypertension practice guidelines for home blood pressure monitoring","volume":"24","author":"Parati","year":"2010","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C67","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/HJH.0b013e328308da66","article-title":"European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring","volume":"26","author":"Parati","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C68","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00004872-199210120-00014","article-title":"Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: implications for studies on antihypertensive drugs","volume":"10","author":"Mancia","year":"1992","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C69","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.HYP.5.2.264","article-title":"Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure","volume":"5","author":"Di Rienzo","year":"1983","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C70","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/HJH.0b013e32835850d7","article-title":"Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis","volume":"30","author":"Stergiou","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00004872-199605000-00003","article-title":"Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis","volume":"14","author":"Fagard","year":"1996","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/HJH.0b013e328334f220","article-title":"Time-weighted vs. conventional quantification of 24-h average systolic and diastolic ambulatory blood pressures","volume":"28","author":"Octavio","year":"2010","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C73","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00004872-199816060-00003","article-title":"Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation","volume":"16","author":"Omboni","year":"1998","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C74","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/08037050410021432","article-title":"Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension","volume":"13","author":"Stenehjem","year":"2004","journal-title":"Blood Press"},{"key":"2026080919364782900_EHT151C75","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/HYPERTENSIONAHA.112.194340","article-title":"Short- and long-term blood pressure variability: present and future","volume":"60","author":"Mancia","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C76","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","article-title":"Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study","volume":"107","author":"Kario","year":"2003","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C77","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ajh.2010.126","article-title":"A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings","volume":"23","author":"Head","year":"2010","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C78","first-page":"S39","article-title":"Blood pressure load and target organ effects in patients with essential hypertension","volume":"9","author":"White","year":"1991","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/01.HYP.0000200695.34024.4c","article-title":"Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring","volume":"47","author":"Li","year":"2006","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C80","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/HJH.0b013e3283509ae2","article-title":"What are the real determinants of the ambulatory arterial stiffness index?","volume":"30","author":"Parati","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/HYPERTENSIONAHA.112.191858","article-title":"Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications","volume":"60","author":"Verdecchia","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C82","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0b013e32830c4368","article-title":"Ambulatory blood pressure monitoring vs. self-measurement of blood pressure at home: correlation with target organ damage","volume":"26","author":"Gaborieau","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C83","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/HJH.0b013e3283531eaf","article-title":"Home vs. ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis","volume":"30","author":"Bliziotis","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C84","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.282.6.539","article-title":"Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators","volume":"282","author":"Staessen","year":"1999","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C85","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa022273","article-title":"Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension","volume":"348","author":"Clement","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C86","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study","volume":"46","author":"Dolan","year":"2005","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C87","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000160923.04524.5B","article-title":"Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study","volume":"111","author":"Sega","year":"2005","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C88","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/HJH.0b013e3282f97854","article-title":"Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis","volume":"26","author":"Conen","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C89","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(07)61538-4","article-title":"Prognostic accuracy of day vs. night ambulatory blood pressure: a cohort study","volume":"370","author":"Boggia","year":"2007","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/HYPERTENSIONAHA.107.100727","article-title":"Daytime and night-time blood pressure as predictors of death and cause-specific cardiovascular events in hypertension","volume":"51","author":"Fagard","year":"2008","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C91","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MBP.0b013e32831054f5","article-title":"Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease","volume":"13","author":"Fagard","year":"2008","journal-title":"Blood Press Monit"},{"key":"2026080919364782900_EHT151C92","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archinternmed.2011.230","article-title":"Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease","volume":"171","author":"Minutolo","year":"2011","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C93","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/HJH.0b013e328350bb40","article-title":"Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study","volume":"30","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.109.133900","article-title":"Predictive role of the night-time blood pressure","volume":"57","author":"Hansen","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C95","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/jhh.2009.9","article-title":"Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension","volume":"23","author":"Fagard","year":"2009","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C96","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/HYPERTENSIONAHA.107.088708","article-title":"Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study","volume":"49","author":"Mancia","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C97","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/hy1001.092640","article-title":"Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives","volume":"38","author":"Kario","year":"2001","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C98","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MBP.0b013e328340c5e4","article-title":"Role of home blood pressure telemonitoring in hypertension management: an update","volume":"15","author":"Parati","year":"2010","journal-title":"Blood Press Monit"},{"key":"2026080919364782900_EHT151C99","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2011.108","article-title":"Hypertension: Does home telemonitoring improve hypertension management?","volume":"7","author":"Stergiou","year":"2011","journal-title":"Nature Rev Nephrol"},{"key":"2026080919364782900_EHT151C100","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.107.104620","article-title":"Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study","volume":"52","author":"Kikuya","year":"2008","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ajh.2010.194","article-title":"Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review","volume":"24","author":"Stergiou","year":"2011","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C102","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/HYPERTENSIONAHA.110.150771","article-title":"Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously","volume":"55","author":"Stergiou","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C103","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/HJH.0b013e32834e4aed","article-title":"Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies","volume":"30","author":"Ward","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C104","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.jhh.1001903","article-title":"Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice","volume":"19","author":"Fagard","year":"2005","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C105","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000215363.69793.bb","article-title":"Long-term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure","volume":"47","author":"Mancia","year":"2006","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C106","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(83)92244-4","article-title":"Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate","volume":"2","author":"Mancia","year":"1983","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C107","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.HYP.31.5.1185","article-title":"Difference between clinic and daytime blood pressure is not a measure of the white-coat effect","volume":"31","author":"Parati","year":"1998","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C108","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00004872-199609000-00001","article-title":"White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next?","volume":"14","author":"Mancia","year":"1996","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C109","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/HJH.0b013e3282ef6185","article-title":"Incidence of cardiovascular events in white-coat, masked and sustained hypertension vs. true normotension: a meta-analysis","volume":"25","author":"Fagard","year":"2007","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C110","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00004872-199400127-00001","article-title":"Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database","volume":"12","author":"Staessen","year":"1994","journal-title":"J Hypertens Suppl"},{"key":"2026080919364782900_EHT151C111","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00126097-200412000-00007","article-title":"Determinants of white-coat hypertension","volume":"9","author":"Dolan","year":"2004","journal-title":"Blood Press Monit"},{"key":"2026080919364782900_EHT151C112","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ajh.2010.203","article-title":"Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis","volume":"24","author":"Pierdomenico","year":"2011","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C113","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/HYPERTENSIONAHA.111.180653","article-title":"Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population","volume":"59","author":"Franklin","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C114","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1161\/hc3701.096100","article-title":"Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study)","volume":"104","author":"Sega","year":"2001","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C115","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1097\/HJH.0b013e32832be5f9","article-title":"Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C116","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/HYPERTENSIONAHA.109.129882","article-title":"Long-term risk of sustained hypertension in white-coat or masked hypertension","volume":"54","author":"Mancia","year":"2009","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C117","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/HJH.0b013e3282fbcedf","article-title":"Masked hypertension: a systematic review","volume":"26","author":"Bobrie","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C118","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11906-010-0140-4","article-title":"Masked hypertension: evidence of the need to treat","volume":"12","author":"Ogedegbe","year":"2010","journal-title":"Current Hypertens Rep"},{"key":"2026080919364782900_EHT151C119","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.HYP.0000160320.39303.ab","article-title":"Prevalence, persistence and clinical significance of masked hypertension in youth","volume":"45","author":"Lurbe","year":"2005","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa013410","article-title":"Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes","volume":"347","author":"Lurbe","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C121","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00125-009-1369-9","article-title":"Masked nocturnal hypertension: a novel marker of risk in type 2 diabetes","volume":"52","author":"Wijkman","year":"2009","journal-title":"Diabetologia"},{"key":"2026080919364782900_EHT151C122","doi-asserted-by":"crossref","first-page":"d3621","DOI":"10.1136\/bmj.d3621","article-title":"Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review","volume":"342","author":"Hodgkinson","year":"2011","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C123","first-page":"p184","article-title":"Blood pressure response to acute physical and mental stress","volume-title":"Manual of Hypertension of the European Society of Hypertension","author":"Fagard","year":"2008"},{"key":"2026080919364782900_EHT151C124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pcad.2008.07.001","article-title":"The blood pressure response to dynamic exercise testing: a systematic review","volume":"51","author":"Le","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080919364782900_EHT151C125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jash.2009.10.003","article-title":"Exercise hypertension: an adverse prognosis?","volume":"3","author":"Smith","year":"2009","journal-title":"J Am Soc Hyper"},{"key":"2026080919364782900_EHT151C126","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.111.180349","article-title":"Insulin resistance, low cardiorespiratory fitness, and increased exercise blood pressure: contribution of abdominal obesity","volume":"58","author":"Huot","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C127","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/HJH.0b013e32834f41b1","article-title":"The relationship between arterial stiffness and increase in blood pressure during exercise in normotensive persons","volume":"30","author":"Sung","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C128","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/jhh.2011.99","article-title":"Exercise blood pressure and the risk of future hypertension","volume":"26","author":"Holmqvist","year":"2012","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/01.HYP.28.1.31","article-title":"Prognostic value of invasive haemodynamic measurements at rest and during exercise in hypertensive men","volume":"28","author":"Fagard","year":"1996","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/00004872-200108000-00001","article-title":"Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men","volume":"19","author":"Kjeldsen","year":"2001","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C131","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ajh.2011.75","article-title":"Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise","volume":"24","author":"Sharman","year":"2011","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C132","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/hrt.2008.162172","article-title":"Augmented blood pressure response to exercise is associated with improved long-term survival in older people","volume":"95","author":"Hedberg","year":"2009","journal-title":"Heart"},{"key":"2026080919364782900_EHT151C133","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.amjcard.2007.06.070","article-title":"Prognostic significance of systolic blood pressure increases in men during exercise stress testing","volume":"100","author":"Gupta","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026080919364782900_EHT151C134","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1741826710393994","article-title":"Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments","volume":"19","author":"Corra","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"2026080919364782900_EHT151C135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PSY.0b013e3182359808","article-title":"Blood pressure reactions to acute mental stress and future blood pressure status: data from the 12-year follow-up of the West of Scotland Study","volume":"73","author":"Carroll","year":"2011","journal-title":"Psychosom Med"},{"key":"2026080919364782900_EHT151C136","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/HYPERTENSIONAHA.109.146621","article-title":"Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence","volume":"55","author":"Chida","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C137","first-page":"624","volume-title":"McDonald's blood flow in arteries; Theoretical, experimental and clinical principles. Fifth Edition","author":"Nichols","year":"2005"},{"key":"2026080919364782900_EHT151C138","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C139","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/hy0202.098325","article-title":"Central pulse pressure and mortality in end-stage renal disease","volume":"39","author":"Safar","year":"2002","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C140","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/eurheartj\/ehq024","article-title":"Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis","volume":"31","author":"Vlachopoulos","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C141","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Re-appraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C142","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/HJH.0b013e32835d8230","article-title":"Guidelines on guidelines: focus on isolated systolic hyprtension in youth","volume":"31","author":"O'Rourke","year":"2013","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C143","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0021-9681(86)90083-4","article-title":"A comparison of positive family history definitions for defining risk of future disease","volume":"39","author":"Hunt","year":"1986","journal-title":"J Chronic Dis"},{"key":"2026080919364782900_EHT151C144","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0091-7435(88)90038-2","article-title":"Precursors of essential hypertension: body weight, alcohol and salt use and parental history of hypertension","volume":"17","author":"Friedman","year":"1988","journal-title":"Prev Med"},{"key":"2026080919364782900_EHT151C145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.HYP.37.2.350","article-title":"Twins in cardiovascular genetic research","volume":"37","author":"Luft","year":"2001","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C146","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.HYP.26.6.919","article-title":"Heritability of conventional and ambulatory blood pressures. A study in twins","volume":"26","author":"Fagard","year":"1995","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C147","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","article-title":"Molecular mechanisms of human hypertension","volume":"104","author":"Lifton","year":"2001","journal-title":"Cell"},{"key":"2026080919364782900_EHT151C148","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"key":"2026080919364782900_EHT151C149","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","article-title":"Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy","volume":"90","author":"Levy","year":"1994","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C150","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events","volume":"292","author":"Okin","year":"2004","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C151","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/01.HYP.0000142169.17298.54","article-title":"Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension","volume":"44","author":"Fagard","year":"2004","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C152","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.108.812313","article-title":"Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)","volume":"119","author":"Okin","year":"2009","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C153","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/eurheartj\/ehp235","article-title":"Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'","volume":"30","author":"Kirchhof","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C154","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1160\/TH11-07-0517","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET\/EHRA consensus conference","volume":"106","author":"Kirchhof","year":"2011","journal-title":"Thromb Haemost"},{"key":"2026080919364782900_EHT151C155","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.CIR.63.6.1391","article-title":"Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings","volume":"63","author":"Reichek","year":"1981","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C156","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C157","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/HJH.0b013e32833d95fe","article-title":"Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk","volume":"28","author":"Tsioufis","year":"2010","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C158","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00004872-200207000-00017","article-title":"Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey","volume":"20","author":"Cuspidi","year":"2002","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C159","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"2026080919364782900_EHT151C160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/HYPERTENSIONAHA.110.150250","article-title":"Left ventricular mass: allometric scaling, normative values, effect of obesity and prognostic performance","volume":"56","author":"Chirinos","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C161","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcmg.2012.06.003","article-title":"LV mass assessed by echocardiography and CMR, cardiovascular outcomes and medical practice","volume":"5","author":"Armstrong","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919364782900_EHT151C162","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","article-title":"Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension","volume":"114","author":"Koren","year":"1991","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C163","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0735-1097(94)00424-O","article-title":"Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass","volume":"25","author":"Verdecchia","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C164","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.HYP.0000121223.44837.de","article-title":"Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients","volume":"43","author":"Muiesan","year":"2004","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C166","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0735-1097(01)01110-X","article-title":"Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study","volume":"37","author":"Aurigemma","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C167","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.0000015076.37047.D9","article-title":"Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study","volume":"105","author":"Bella","year":"2002","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C168","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026080919364782900_EHT151C169","first-page":"194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA","volume":"289","author":"Redfield","year":"2003"},{"key":"2026080919364782900_EHT151C170","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.amjcard.2005.01.021","article-title":"Effects of age, gender and left ventricular mass on septal mitral annulus velocity (E') and the ratio of transmitral early peak velocity to E' (E\/E')","volume":"95","author":"De Sutter","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026080919364782900_EHT151C171","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/eurheartj\/ehp498","article-title":"Tissue Doppler E\/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT sub-study","volume":"31","author":"Sharp","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C172","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2006.02.048","article-title":"Left atrial size: physiologic determinants and clinical applications","volume":"47","author":"Abhayaratna","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C173","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ejechocard\/jer021","article-title":"Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography","volume":"12","author":"Mor-Avi","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"2026080919364782900_EHT151C174","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.echo.2010.07.010","article-title":"Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study","volume":"23","author":"Galderisi","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919364782900_EHT151C175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCIMAGING.111.966754","article-title":"Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm","volume":"5","author":"Codella","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919364782900_EHT151C176","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1532-429X-14-54","article-title":"Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies","volume":"14","author":"Parsai","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919364782900_EHT151C177","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00004872-200107000-00001","article-title":"Diagnosis of myocardial ischemia in hypertensive patients","volume":"19","author":"Picano","year":"2001","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C178","first-page":"1226","article-title":"Non-invasive diagnostic testing for coronary artery disease in the hypertensive patient: potential advantages of a risk estimation-based algorithm","volume":"25","author":"Chin","year":"2012","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C179","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.HYP.10.1.16","article-title":"Thallium-201 stress imaging in hypertensive patients","volume":"10","author":"Schulman","year":"1987","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurheartj\/ehn492","article-title":"Stress Echocardiography Expert Consensus Statement: Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC)","volume":"30","author":"Sicari","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C181","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(11)61335-4","article-title":"Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial","volume":"379","author":"Greenwood","year":"2012","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C182","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/heartjnl-2011-300178","article-title":"Diagnostic and prognostic value of Doppler echocardiographic coronary flow reserve in the left anterior descending artery in hypertensive and normotensive patients [corrected]","volume":"97","author":"Cortigiani","year":"2011","journal-title":"Heart"},{"key":"2026080919364782900_EHT151C183","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.96.5.1432","article-title":"Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study","volume":"96","author":"Bots","year":"1997","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C184","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group","volume":"340","author":"O'Leary","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C185","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2009.11.075","article-title":"Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study","volume":"55","author":"Nambi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C186","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.CIR.0000039288.86470.DD","article-title":"Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial","volume":"106","author":"Zanchetti","year":"2002","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C187","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000081812","article-title":"Mannheim intima-media thickness consensus","volume":"18","author":"Touboul","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"2026080919364782900_EHT151C188","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCULATIONAHA.108.773119","article-title":"Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA)","volume":"120","author":"Zanchetti","year":"2009","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C189","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/heartjnl-2011-300747","article-title":"Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review","volume":"98","author":"Peters","year":"2012","journal-title":"Heart"},{"key":"2026080919364782900_EHT151C190","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000069826.36125.B4","article-title":"Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases","volume":"107","author":"Safar","year":"2003","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C191","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","article-title":"Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity","volume":"30","author":"Van Bortel","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C192","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C193","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C194","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/hy0102.099031","article-title":"Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study","volume":"39","author":"Boutouyrie","year":"2002","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.105.555235","article-title":"Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study","volume":"113","author":"Mattace-Raso","year":"2006","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C196","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.109.886655","article-title":"Arterial stiffness and cardiovascular events: the Framingham Heart Study","volume":"121","author":"Mitchell","year":"2010","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C197","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinte.166.5.529","article-title":"The long-term prognostic value of the resting and postexercise ankle-brachial index","volume":"166","author":"Feringa","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C198","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C199","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pcad.2007.08.001","article-title":"Management of hypertension in peripheral arterial disease","volume":"50","author":"De Buyzere","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080919364782900_EHT151C200","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00004872-200105000-00013","article-title":"Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension","volume":"19","author":"Park","year":"2001","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C201","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1161\/01.CIR.0000041432.80615.A5","article-title":"Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia","volume":"106","author":"Schofield","year":"2002","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C202","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.CIR.0000095031.51492.C5","article-title":"Prognostic significance of small-artery structure in hypertension","volume":"108","author":"Rizzoni","year":"2003","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C203","first-page":"e584","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"122","author":"Greenland","year":"2010","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C204","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/eurheartj\/ehq235","article-title":"Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology","volume":"32","author":"Perrone-Filardi","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","article-title":"Endothelial function: cardiac events","volume":"111","author":"Lerman","year":"2005","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C206","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-S330","article-title":"Endothelial dysfunction as a target for prevention of cardiovascular disease","volume":"32","author":"Versari","year":"2009","journal-title":"Diabetes Care"},{"key":"2026080919364782900_EHT151C207","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function: measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C208","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2004.03.027","article-title":"Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay","volume":"44","author":"Hallan","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2026080919364782900_EHT151C209","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estmated glomerular filtration rate","volume":"307","author":"Matsushita","year":"2012","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C210","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"2026080919364782900_EHT151C211","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2026080919364782900_EHT151C212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C213","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"2026080919364782900_EHT151C214","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199611283352212","article-title":"Initiation and progression of diabetic nephropathy","volume":"335","author":"Parving","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C215","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/00041552-199311000-00017","article-title":"Clinical relevance of proteinuria and microalbuminuria","volume":"2","author":"Ruilope","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026080919364782900_EHT151C216","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200203000-00002","article-title":"Microalbuminuria in essential hypertension: redefining the threshold","volume":"20","author":"Redon","year":"2002","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C217","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.HYP.35.4.898","article-title":"Arterial hypertension, microalbuminuria and risk of ischemic heart disease","volume":"35","author":"Jensen","year":"2000","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C218","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1001\/archinte.164.22.2459","article-title":"Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial","volume":"164","author":"de Leeuw","year":"2004","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C219","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C221","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-139-11-200312020-00008","article-title":"Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study","volume":"139","author":"Wachtell","year":"2003","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C222","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.ATV.19.3.617","article-title":"Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study","volume":"19","author":"Jager","year":"1999","journal-title":"Arterioscler Thromb Vac Biol"},{"key":"2026080919364782900_EHT151C223","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/00004872-199816090-00014","article-title":"Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension","volume":"16","author":"Bigazzi","year":"1998","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C224","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Executive summary","volume":"43","author":"National Kidney Foundation","year":"2004","journal-title":"Am J Kid Dis"},{"key":"2026080919364782900_EHT151C225","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","article-title":"Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study","volume":"112","author":"Arnlov","year":"2005","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C226","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C227","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2026080919364782900_EHT151C228","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C229","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200106000-00021","article-title":"Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group","volume":"19","author":"Zanchetti","year":"2001","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C230","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study","volume":"12","author":"Ruilope","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2026080919364782900_EHT151C231","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/01.ASN.0000027871.86296.92","article-title":"Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial","volume":"13","author":"De Leeuw","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2026080919364782900_EHT151C232","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/00004872-200409000-00001","article-title":"On the importance of estimating renal function for cardiovascular risk assessment","volume":"22","author":"Segura","year":"2004","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C233","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7326\/0003-4819-144-3-200602070-00005","article-title":"Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate","volume":"144","author":"Rahman","year":"2006","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C234","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.1966.03100050043015","article-title":"Prognostic importance of ophthalmoscopic findings in essential hypertension","volume":"195","author":"Breslin","year":"1966","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archinte.1950.00230110002001","article-title":"Prognosis of vascular hypertension; a 9 year follow-up study of 418 cases","volume":"85","author":"Frant","year":"1950","journal-title":"Arch Intern Med (Chic)"},{"key":"2026080919364782900_EHT151C236","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMra032865","article-title":"Hypertensive retinopathy","volume":"351","author":"Wong","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C237","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.111.049965","article-title":"Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study","volume":"124","author":"Sairenchi","year":"2011","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C238","first-page":"248","article-title":"Ophthalmoscopy vs. non-mydriatic fundus photography in the detection of diabetic retinopathy in black patients","volume":"78","author":"Mollentze","year":"1990","journal-title":"S Afr Med J"},{"key":"2026080919364782900_EHT151C239","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(89)92384-2","article-title":"Usefulness of ophthalmoscopy in mild to moderate hypertension","volume":"1","author":"Dimmitt","year":"1989","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.331.7508.73","article-title":"Value of routine funduscopy in patients with hypertension: systematic review","volume":"331","author":"van den Born","year":"2005","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C241","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/aje\/kwp306","article-title":"Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis","volume":"170","author":"McGeechan","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2026080919364782900_EHT151C242","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.34.4.655","article-title":"Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality","volume":"34","author":"Antonios","year":"1999","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C243","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1172\/JCI119354","article-title":"Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure","volume":"99","author":"Noon","year":"1997","journal-title":"J Clin Invest"},{"key":"2026080919364782900_EHT151C244","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/00004872-200411000-00010","article-title":"Retinal microvascular changes and target organ damage in untreated essential hypertensives","volume":"22","author":"Cuspidi","year":"2004","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C245","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0161-6420(99)90525-0","article-title":"Methods for evaluation of retinal microvascular abnormalities associated with hypertension\/sclerosis in the Atherosclerosis Risk in Communities Study","volume":"106","author":"Hubbard","year":"1999","journal-title":"Ophthalmology"},{"key":"2026080919364782900_EHT151C246","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1167\/iovs.03-1390","article-title":"Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study","volume":"45","author":"Ikram","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026080919364782900_EHT151C247","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ophtha.2003.09.039","article-title":"Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes and effect of refractive errors","volume":"111","author":"Wong","year":"2004","journal-title":"Ophthalmology"},{"key":"2026080919364782900_EHT151C248","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1167\/iovs.07-1450","article-title":"Retinal vascular caliber, blood pressure and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study","volume":"49","author":"Sun","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026080919364782900_EHT151C249","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ajh.2011.166","article-title":"Remodeling of retinal small arteries in hypertension","volume":"24","author":"Lehmann","year":"2011","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C250","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.STR.27.8.1274","article-title":"Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study","volume":"27","author":"Longstreth","year":"1996","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C251","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/awf077","article-title":"Hypertension and cerebral white matter lesions in a prospective cohort study","volume":"125","author":"de Leeuw","year":"2002","journal-title":"Brain"},{"key":"2026080919364782900_EHT151C252","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","article-title":"Silent brain infarcts: a systematic review","volume":"6","author":"Vermeer","year":"2007","journal-title":"Lancet Neurology"},{"key":"2026080919364782900_EHT151C253","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.288.1.67","article-title":"Cerebral white matter lesions, retinopathy and incident clinical stroke","volume":"288","author":"Wong","year":"2002","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C254","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1161\/STROKEAHA.109.548222","article-title":"Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study","volume":"40","author":"Buyck","year":"2009","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C255","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/STROKEAHA.108.532853","article-title":"Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints","volume":"40","author":"Kearney-Schwartz","year":"2009","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C256","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/HJH.0b013e3283232c96","article-title":"Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients","volume":"27","author":"Henskens","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C257","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/HYPERTENSIONAHA.109.128744","article-title":"Change in blood pressure and incident dementia: a 32-year prospective study","volume":"54","author":"Stewart","year":"2009","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C258","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C259","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.31.3.780","article-title":"Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men","volume":"31","author":"Kilander","year":"1998","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C260","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/oxfordjournals.bmb.a072892","article-title":"Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease","volume":"50","author":"Collins","year":"1994","journal-title":"Br Med Bull"},{"key":"2026080919364782900_EHT151C261","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","article-title":"Prognostic significance of left ventricular mass change during treatment of hypertension","volume":"292","author":"Devereux","year":"2004","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C262","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","article-title":"Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study","volume":"45","author":"Ibsen","year":"2005","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C263","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.93.4.697","article-title":"Secular trends in long-term sustained hypertension, long-term treatment and cardiovacsular mortality. The Framngham Heart Study 1950 to 1990","volume":"93","author":"Sytkowski","year":"1996","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C264","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C265","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/HJH.0b013e32832aa6b5","article-title":"When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical re-appraisal","volume":"27","author":"Zanchetti","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C266","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"Medical Research Council Working Party. MRC trial on treatment of mild hypertension: principal results","volume":"291","year":"1985","journal-title":"Br Med J"},{"key":"2026080919364782900_EHT151C267","first-page":"1261","volume":"1","author":"Management Committee. The Australian therapeutic trial in mild hypertension","year":"1980","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C268","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1056\/NEJM198210143071603","article-title":"Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in \"mild\" hypertension: results of the Hypertension Detection and Follow-up Program","volume":"307","year":"1982","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C269","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C270","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr039","article-title":"Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial","volume":"32","author":"Zhang","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C271","author":"National Institute for Health and Clinical Excellence","journal-title":"Hypertension (CG127): clinical management of primary hypertension in adults"},{"key":"2026080919364782900_EHT151C272","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/HJH.0b013e32832e9500","article-title":"Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?","volume":"27","author":"Zanchetti","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C273","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":"ACCF\/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists and European Society of Hypertension","volume":"57","author":"Aronow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C274","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","article-title":"Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes","volume":"61","author":"Schrier","year":"2002","journal-title":"Kidney Int"},{"key":"2026080919364782900_EHT151C275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Heart Outcomes Prevention Evaluation Study InvestigatorsEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub-study","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C276","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"ADVANCE Collaborative Group","year":"2007","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C277","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc07-1868","article-title":"Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial","volume":"31","author":"DREAM Trial Investigators","year":"2008","journal-title":"Diabetes Care"},{"key":"2026080919364782900_EHT151C278","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events","volume":"362","author":"The NAVIGATOR study Group","year":"2010","journal-title":"N Eng J Med"},{"key":"2026080919364782900_EHT151C279","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result","volume":"108","author":"PATS Collaborating Group","year":"1995","journal-title":"Chin Med J (Engl)"},{"key":"2026080919364782900_EHT151C280","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C281","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/HJH.0b013e32834000be","article-title":"The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials","volume":"29","author":"Czernichow","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C282","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2011.250","article-title":"Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis","volume":"305","author":"Thompson","year":"2011","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C283","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/STROKEAHA.111.636829","article-title":"Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials","volume":"43","author":"Sipahi","year":"2012","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C284","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C285","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa060838","article-title":"Feasibility of treating prehypertension with an angiotensin receptor blocker","volume":"354","author":"Julius","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C286","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/HJH.0b013e3282ff8864","article-title":"The PHARAO Study: prevention of hypertension with the angiotensin converting enzyme inhibitor ramipril in patients with high normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League","volume":"26","author":"Luders","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C287","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C288","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","article-title":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)","volume":"31","author":"JATOS Study Group","year":"2008","journal-title":"Hypertens Res"},{"key":"2026080919364782900_EHT151C289","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","article-title":"Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study","volume":"56","author":"Ogihara","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C290","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C291","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Co-operative Research Group","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C292","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","article-title":"Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators","volume":"340","author":"Tuomilehto","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C293","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Br Med J"},{"key":"2026080919364782900_EHT151C294","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/HJH.0b013e3283469976","article-title":"Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients","volume":"29","author":"Reboldi","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C295","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"The ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C296","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C297","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C298","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"The European Trial on reduction of cardiac events with Perindopril in stable coronary artery disease Investigators","year":"2003","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C299","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C300","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.102.13.1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators","volume":"102","author":"Pitt","year":"2000","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C301","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C302","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"The PEACE Trial Investigators","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C303","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1681\/ASN.2010030236","article-title":"Blood pressure control in chronic kidney disease: is less really more?","volume":"21","author":"Lewis","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026080919364782900_EHT151C304","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C305","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C306","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C307","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C308","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C309","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C310","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C311","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"The ESCAPE Trial Group. Strict blood-pressure control and progression of renal failure in children","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C312","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004349.pub2","article-title":"Treatment blood pressure targets for hypertension","author":"Arguedas","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C313","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C314","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/eurheartj\/ehq281","article-title":"Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve","volume":"31","author":"Zanchetti","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C315","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C316","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1681\/ASN.2004090763","article-title":"Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial","volume":"16","author":"Berl","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026080919364782900_EHT151C317","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C318","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/HJH.0b013e32832d7370","article-title":"Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study","volume":"27","author":"Sleight","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C319","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/HJH.0b013e3283516499","article-title":"Impact of lower achieved blood pressure on outcomes in hypertensive patients","volume":"30","author":"Okin","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C320","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-136-6-200203190-00007","article-title":"J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data","volume":"136","author":"Boutitie","year":"2002","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C321","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/archinte.167.17.1884","article-title":"On-treatment diastolic blood pressure and prognosis in systolic hypertension","volume":"167","author":"Fagard","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C322","first-page":"A217","article-title":"J-Curve revisited: an analysis of the Treating to New Targets (TNT) Trial","volume":"53","author":"Bangalore","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C323","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/CIRCULATIONAHA.109.905687","article-title":"What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial","volume":"122","author":"Bangalore","year":"2010","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C324","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/CIRCULATIONAHA.110.008870","article-title":"Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)","volume":"124","author":"Mancia","year":"2011","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C325","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2011.1650","article-title":"Level of systolic blood pressure within the normal range and risk of recurrent stroke","volume":"306","author":"Ovbiagele","year":"2011","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C326","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2011.09.040","article-title":"Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)","volume":"59","author":"Redon","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C327","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C328","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual vs. tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C329","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C330","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.CIR.0000083724.28630.C3","article-title":"Regression of electrocardiographic left ventricular hypertrophy by losartan vs. atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study","volume":"108","author":"Okin","year":"2003","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C331","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C332","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/HJH.0b013e328351b4e4","article-title":"Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management: is nice always good?","volume":"30","author":"Zanchetti","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C333","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/HYPERTENSIONAHA.112.199562","article-title":"Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)","volume":"60","author":"Mancia","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C334","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.1997.03550130039034","article-title":"Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators","volume":"278","author":"Staessen","year":"1997","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C335","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jama.291.8.955","article-title":"Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial","volume":"291","author":"Staessen","year":"2004","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C336","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/HYPERTENSIONAHA.107.094193","article-title":"Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial","volume":"50","author":"Verberk","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C337","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-144-7-200604040-00007","article-title":"Effects of comprehensive lifestyle modification on diet, weight, physical fitness and blood pressure control: 18-month results of a randomized trial","volume":"144","author":"Elmer","year":"2006","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C338","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/eurheartj\/ehr379","article-title":"Beyond salt: lifestyle modifications and blood pressure","volume":"32","author":"Frisoli","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C339","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.hjh.0000199800.72563.26","article-title":"Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials","volume":"24","author":"Dickinson","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C340","article-title":"Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition","volume":"8","author":"Groppelli","year":"1990","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C341","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00004872-199205000-00014","article-title":"Persistent blood pressure increase induced by heavy smoking","volume":"10","author":"Groppelli","year":"1992","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C342","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/jama.1991.03460170080037","article-title":"Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study","volume":"265","author":"Mann","year":"1991","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C343","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/HYPERTENSIONAHA.111.180885","article-title":"High dietary salt and angiotensin II chronically increase renal sympathetic nerve activity: a direct telemetric study","volume":"59","author":"Guild","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C344","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","article-title":"Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial","volume":"54","author":"Pimenta","year":"2009","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ajh.2011.210","article-title":"Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol and triglyceride (Cochrane Review)","volume":"25","author":"Graudal","year":"2012","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C346","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/01.HYP.0000102864.05174.E8","article-title":"How far should salt intake be reduced?","volume":"42","author":"He","year":"2003","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C347","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMoa0907355","article-title":"Projected effect of dietary salt reductions on future cardiovascular disease","volume":"362","author":"Bibbins-Domingo","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C348","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(11)61174-4","article-title":"Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials","volume":"378","author":"He","year":"2011","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C349","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review)","volume":"24","author":"Taylor","year":"2011","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C350","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1093\/eurheartj\/ehr194","article-title":"Nutrition in cardiovascular disease: salt in hypertension and heart failure","volume":"32","author":"He","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C351","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C352","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/eurheartj\/ehs409","article-title":"Salt intake and cardiovascular disease: why are the data inconsistent?","volume":"34","author":"O'Donnell","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C353","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/hrt.2010.199240","article-title":"Cost-effectiveness of interventions to reduce dietary salt intake","volume":"96","author":"Cobiac","year":"2010","journal-title":"Heart"},{"key":"2026080919364782900_EHT151C354","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(87)90413-2","article-title":"Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial","volume":"1","author":"Puddey","year":"1987","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C355","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.158.11.1197","article-title":"Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure","volume":"158","author":"Cushman","year":"1998","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C356","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinternmed.2009.38","article-title":"A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease","volume":"169","author":"Mente","year":"2009","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C357","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3945\/ajcn.2010.29673","article-title":"Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis","volume":"92","author":"Sofi","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"2026080919364782900_EHT151C358","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Eng J Med"},{"key":"2026080919364782900_EHT151C359","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/jn\/132.7.1900","article-title":"Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension","volume":"132","author":"Rivas","year":"2002","journal-title":"J Nutr"},{"key":"2026080919364782900_EHT151C360","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archinternmed.2009.470","article-title":"Effects of the DASH diet al. one and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study","volume":"170","author":"Blumenthal","year":"2010","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C361","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/HJH.0b013e3283588d73","article-title":"The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis","volume":"30","author":"Stessen","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C362","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/08037050701715117","article-title":"Undiagnosed obesity in hypertension: clinical and therapeutic implications","volume":"16","author":"Romero","year":"2007","journal-title":"Blood Press"},{"key":"2026080919364782900_EHT151C363","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"issue":"1083","key":"2026080919364782900_EHT151C364","first-page":"1096","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Prospective Studies Collaboration","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories. A systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C366","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003817.pub3","article-title":"Exercise for overweight or obesity","author":"Shaw","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C367","article-title":"Long-term non-pharmacological weight loss interventions for adults with pre-diabetes","author":"Norris","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C368","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/HJH.0b013e3283537347","article-title":"Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension","volume":"30","author":"Jordan","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C369","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.HYP.0000184225.05629.51","article-title":"Effects of endurance training on blood pressure, blood pressure-regulating mechanisms and cardiovascular risk factors","volume":"46","author":"Cornelissen","year":"2005","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C370","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1001\/archinte.167.22.2453","article-title":"Physical activity recommendations and decreased risk of mortality","volume":"167","author":"Leitzmann","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C371","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/HJH.0b013e3283544669","article-title":"The impact of physical activity on mortality in patients with high blood pressure: a systematic review","volume":"30","author":"Rossi","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C372","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/HJH.0b013e3283551eb2","article-title":"Physical activity, fitness, mortality","volume":"30","author":"Fagard","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C373","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pcad.2011.03.006","article-title":"Exercise therapy in hypertensive cardiovascular disease","volume":"53","author":"Fagard","year":"2011","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080919364782900_EHT151C374","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1741826711400512","article-title":"Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients","volume":"19","author":"Molmen-Hansen","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"2026080919364782900_EHT151C375","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.111.177071","article-title":"Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials","volume":"58","author":"Cornelissen","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C376","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/1741826711430926","article-title":"Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR. Part II","volume":"19","author":"Vanhees","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"2026080919364782900_EHT151C377","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ypmed.2004.09.022","article-title":"Inequalities in the prevalence of smoking in the European Union: comparing education and income","volume":"40","author":"Huisman","year":"2005","journal-title":"Prev Med"},{"key":"2026080919364782900_EHT151C378","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MBP.0b013e32833e439f","article-title":"Acute effects of passive smoking on blood pressure and heart rate in healthy females","volume":"15","author":"Yarlioglues","year":"2010","journal-title":"Blood Press Monit"},{"key":"2026080919364782900_EHT151C379","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.90.1.248","article-title":"Mechanisms responsible for sympathetic activation by cigarette smoking in humans","volume":"90","author":"Grassi","year":"1994","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C380","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.CIR.98.6.528","article-title":"Cigarette smoking increases sympathetic outflow in humans","volume":"98","author":"Narkiewicz","year":"1998","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C381","article-title":"Smoking impairs baroreflex sensitivity in humans","volume":"273","author":"Mancia","year":"1997","journal-title":"Am J Physiol"},{"key":"2026080919364782900_EHT151C382","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126097-200010000-00004","article-title":"Do we undertreat hypertensive smokers? A comparison between smoking and non-smoking hypertensives","volume":"5","author":"Bang","year":"2000","journal-title":"Blood Press Monit"},{"key":"2026080919364782900_EHT151C383","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.HYP.37.2.187","article-title":"Association between smoking and blood pressure: evidence from the health survey for England","volume":"37","author":"Primatesta","year":"2001","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C384","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/bmj.309.6959.901","article-title":"Mortality in relation to smoking: 40 years' observations on male British doctors","volume":"309","author":"Doll","year":"1994","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C385","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198512123132404","article-title":"The risk of myocardial infarction after quitting smoking in men under 55 years of age","volume":"313","author":"Rosenberg","year":"1985","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C386","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199205213262107","article-title":"The primary prevention of myocardial infarction","volume":"326","author":"Manson","year":"1992","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C387","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000165.pub2","article-title":"Physician advice for smoking cessation","author":"Lancaster","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C388","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub4","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Cahill","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C389","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000031.pub3","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C390","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003999.pub3","article-title":"Relapse prevention interventions for smoking cessation","author":"Hajek","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C391","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C392","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/HJH.0b013e3283281254","article-title":"Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients","volume":"27","author":"Costanzo","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C393","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","article-title":"Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients","volume":"33","author":"van Vark","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C394","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archinte.165.12.1410","article-title":"Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials","volume":"165","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2005","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C395","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C396","author":"Wiyonge","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C397","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/01.hjh.0000249685.58370.28","article-title":"How strong is the evidence for use of beta-blockers as first line therapy for hypertension?","volume":"24","author":"Bradley","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C398","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","article-title":"Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study","volume":"113","author":"Williams","year":"2006","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C399","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/HYPERTENSIONAHA.109.148999","article-title":"Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study","volume":"55","author":"Boutouyrie","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C400","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ehj.2003.08.016","article-title":"Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side-effects and is reversed by placebo","volume":"24","author":"Silvestri","year":"2003","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C401","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.HYP.37.2.250","article-title":"Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis","volume":"37","author":"Sharma","year":"2001","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C402","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C403","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1097\/HJH.0b013e3282f063d5","article-title":"Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness","volume":"25","author":"Zanchetti","year":"2007","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C404","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/01.CIR.101.22.2601","article-title":"Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment","volume":"101","author":"Boutouyrie","year":"2000","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C405","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/HJH.0b013e3282f283c9","article-title":"A comparison of atenolol and nebivolol in isolated systolic hypertension","volume":"26","author":"Dhakam","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C406","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/HYPERTENSIONAHA.110.155507","article-title":"Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness","volume":"57","author":"Kampus","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C407","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C408","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.hjh.0000209993.26057.de","article-title":"Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients","volume":"24","author":"Celik","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C409","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.111.189381","article-title":"A double-blind, placebo-controlled, crossover trial comparing the effects of amiloride and hydrochlorothiazide on glucose tolerance in patients with essential hypertension","volume":"59","author":"Stears","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C410","first-page":"1787","article-title":"Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C411","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-Blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C412","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.1977.03270300059008","article-title":"Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. A co-operative study","volume":"237","year":"1977","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C413","first-page":"7","article-title":"Report of a WHO expert committee","author":"Arterial hypertension","year":"1978","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2026080919364782900_EHT151C414","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C415","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrcardio.2011.39","article-title":"Hypertension meta-analyses: first rank evidence or second hand information?","volume":"14","author":"Zanchetti","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2026080919364782900_EHT151C416","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2010.07.053","article-title":"Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring. A meta-analysed of randomized trials","volume":"57","author":"Messerli","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C417","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","article-title":"Chlortalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses","volume":"59","author":"Roush","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C418","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/HYPERTENSIONAHA.110.161505","article-title":"Chlortalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis","volume":"57","author":"Dorsch","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C419","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C421","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.HYP.0000174591.42889.a2","article-title":"Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention","volume":"46","author":"Verdecchia","year":"2005","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C422","first-page":"204","article-title":"Calcium channel blockers in hypertension","volume-title":"Hypertension, a companion to Braunwald Heart Disease","author":"Zanchetti","year":"2012"},{"key":"2026080919364782900_EHT151C423","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required vs. atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) a multicentre randomised controlled trial","volume":"366","author":"Dalhof","year":"2005","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C424","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.105.594986","article-title":"Do angiotensin receptor blockers increase the risk of myocardial infarction?: Angiotensin Receptor Blockers May increase risk of Myocardial Infarction: Unraveling the ARB-MI Paradox","volume":"114","author":"Strauss","year":"2006","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C425","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"The Lancet Oncology"},{"key":"2026080919364782900_EHT151C426","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/HJH.0b013e328344a7de","article-title":"Effects of telmisartan, irbesartan, valsartan, candesartan and losartan on cancers in 15 trials enrolling 138,769 individuals","volume":"29","author":"ARB Trialists collaboration","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C427","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/ehq382","article-title":"Twisting arms to angiotensin receptor blockers\/antagonists: the turn of cancer","volume":"32","author":"Volpe","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C428","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.0000156466.02908.ED","article-title":"Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients","volume":"111","author":"Gradman","year":"2005","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C429","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.HYP.0000253780.36691.4f","article-title":"Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker","volume":"49","author":"O'Brien","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C430","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1185\/03007990902785845","article-title":"Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension","volume":"25","author":"Littlejohn","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"2026080919364782900_EHT151C431","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C432","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ejheart.2007.09.002","article-title":"Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure","volume":"9","author":"Seed","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026080919364782900_EHT151C433","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal endpoints in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C434","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure. The ASTRONAUT Randomized Trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C435","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic significance of visit-to-visit variability, maximum systolic blood pressure and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C436","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/HYPERTENSIONAHA.107.090290","article-title":"Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study","volume":"50","author":"Mancia","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C437","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.107565","article-title":"Visit-to-Visit Blood Pressure Variability, Carotid Atherosclerosis and Cardiovascular Events in the European Lacidipine Study on Atherosclerosis","volume":"126","author":"Mancia","year":"2012","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C438","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurology"},{"key":"2026080919364782900_EHT151C439","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","article-title":"Effects of antihypertensive-drug class on inter-individual variation in blood pressure and risk of stroke: a systematic review and meta-analysis","volume":"375","author":"Webb","year":"2010","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C440","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.611566","article-title":"Effect of dose and combination of antihypertensives on inter-individual blood pressure variability: a systematic review","volume":"42","author":"Webb","year":"2011","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C441","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/HJH.0b013e32835339ac","article-title":"Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment","volume":"30","author":"Mancia","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C442","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/STROKEAHA.111.626747","article-title":"Wars, war games and dead bodies on the battlefield: variations on the theme of blood pressure variability","volume":"42","author":"Zanchetti","year":"2011","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C443","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/HJH.0b013e3282f52fa8","article-title":"Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage","volume":"26","author":"Mancia","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C444","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials","volume":"336","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2008","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C445","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/eurheartj\/ehn427","article-title":"Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials","volume":"29","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C446","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy vs. monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"2026080919364782900_EHT151C447","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/HJH.0b013e328339f9fa","article-title":"Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice","volume":"28","author":"Corrao","year":"2010","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C448","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"ALLHAT officers and co-ordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C449","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","author":"SHEP Co-operative Research Group","year":"1991","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C450","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C451","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C452","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","article-title":"Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group","volume":"16","author":"Liu","year":"1998","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C453","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.293.6555.1145","article-title":"Randomised trial of treatment of hypertension in elderly patients in primary care","volume":"293","author":"Coope","year":"1986","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C454","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","article-title":"Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)","volume":"338","author":"Dahlof","year":"1991","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C455","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C456","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"VALUE trial group.Outcomes inhypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C457","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C458","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"CONVINCE Trial group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C459","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"INVEST investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C460","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C461","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C462","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","article-title":"New-onset diabetes and antihypertensive drugs","volume":"24","author":"Mancia","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C463","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"ONTARGET Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C464","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.109.131466","article-title":"Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients","volume":"54","author":"Matsui","year":"2009","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C465","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C466","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the association between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"2026080919364782900_EHT151C467","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(09)60611-5","article-title":"Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double blind, randomised trial","volume":"373","author":"Indian Polycap Study (TIPS)","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C468","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.CIR.102.10.1139","article-title":"Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"102","author":"Fagard","year":"2000","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C469","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.0000054622.45012.12","article-title":"Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men","volume":"107","author":"Bjorklund","year":"2003","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C470","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(85)91783-0","article-title":"Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial","volume":"1","author":"Amery","year":"1985","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C471","first-page":"405","article-title":"MRC Working Party","volume":"304","author":"Medical Research Council trial of treatment of hypertension in older adults: principal results","year":"1992","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C472","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d643","article-title":"Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts","volume":"342","author":"Sundstrom","year":"2011","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C473","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCOUTCOMES.110.868307","article-title":"Representation of women in randomized clinical trials of cardiovascular disease prevention","volume":"3","author":"Melloni","year":"2010","journal-title":"Circulation Cardiovascular quality and outcomes"},{"key":"2026080919364782900_EHT151C474","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0025-6196(11)60993-2","article-title":"Low rate of sex-specific result reporting in cardiovascular trials","volume":"82","author":"Blauwet","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2026080919364782900_EHT151C475","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-126-10-199705150-00002","article-title":"Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators","volume":"126","author":"Gueyffier","year":"1997","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C476","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00004872-199715100-00003","article-title":"Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994","volume":"15","author":"Dong","year":"1997","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C477","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C478","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2125.2006.02747.x","article-title":"The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate","volume":"63","author":"Atthobari","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"2026080919364782900_EHT151C479","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697130500330341","article-title":"Drospirenone in combination with estrogens: for contraception and hormone replacement therapy","volume":"8","author":"Oelkers","year":"2005","journal-title":"Climacteric"},{"key":"2026080919364782900_EHT151C480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13625187.2011.643836","article-title":"Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis","volume":"17","author":"Martinez","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2026080919364782900_EHT151C481","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM198808043190503","article-title":"A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women","volume":"319","author":"Stampfer","year":"1988","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C482","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","article-title":"Oral contraceptives and myocardial infarction: results of the MICA case-control study","volume":"318","author":"Dunn","year":"1999","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C483","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C484","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fertnstert.2006.11.206","article-title":"A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women","volume":"88","author":"Margolis","year":"2007","journal-title":"Fertility and Sterility"},{"key":"2026080919364782900_EHT151C485","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.2010-2065","article-title":"Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis","volume":"96","author":"Chakhtoura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080919364782900_EHT151C486","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: A meta-analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C487","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.164.7.741","article-title":"Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence","volume":"164","author":"Chan","year":"2004","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C488","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080919364782900_EHT151C489","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"key":"2026080919364782900_EHT151C490","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C491","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C492","volume-title":"Medical eligibility criteria for contraceptive use. 3rd ed","author":"World Health Organization","year":"2004"},{"key":"2026080919364782900_EHT151C493","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jhh.1001841","article-title":"Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension","volume":"19","author":"Lubianca","year":"2005","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C494","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"No. 73: Use of hormonal contraception in women with coexisting medical conditions","volume":"107","author":"ACOG Committee on practice bulletin - Gynecology ACOG practice bulletin","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2026080919364782900_EHT151C495","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women: 2011 update: a guideline from the American Heart Association","volume":"57","author":"Mosca","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C496","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/eurheartj\/ehm296","article-title":"Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists","volume":"28","author":"Collins","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C497","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.maturitas.2004.01.010","article-title":"Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women","volume":"49","author":"Mueck","year":"2004","journal-title":"Maturitas"},{"key":"2026080919364782900_EHT151C498","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr272","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C499"},{"key":"2026080919364782900_EHT151C500","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","author":"Abalos","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C501","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1161\/STROKEAHA.110.610592","article-title":"Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern?","volume":"42","author":"Kuklina","year":"2011","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C502","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.AOG.0000151116.84113.56","article-title":"Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure","volume":"105","author":"Martin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2026080919364782900_EHT151C503","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2011.04.010","article-title":"Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis","volume":"158","author":"Rossi","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026080919364782900_EHT151C505","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2026080919364782900_EHT151C506","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C507","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses","volume":"156","author":"McDonald","year":"2008","journal-title":"Am Heart J"},{"key":"2026080919364782900_EHT151C508","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00125-009-1457-x","article-title":"Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial","volume":"52","author":"Beulens","year":"2009","journal-title":"Diabetologia"},{"key":"2026080919364782900_EHT151C509","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C510","volume-title":"Diabetic autonomic failure","author":"Watkins","year":"1999"},{"key":"2026080919364782900_EHT151C511","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1097\/HJH.0b013e3283577bdf","article-title":"Blood pressure and risk of cardiovascular disease in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP-II)","volume":"30","author":"Cederholm","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C512","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensives patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C513","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C514","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C515","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.amjcard.2008.03.037","article-title":"All-cause and cardiovascular mortality using the different definitions of metabolic syndrome","volume":"102","author":"Benetos","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026080919364782900_EHT151C516","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1464-5491.2007.02142.x","article-title":"The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects: a population-based study comparing three different definitions","volume":"24","author":"Nilsson","year":"2007","journal-title":"Diabet Med"},{"key":"2026080919364782900_EHT151C517","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.HYP.0000251933.22091.24","article-title":"Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage and prognosis","volume":"49","author":"Mancia","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C518","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/HYPERTENSIONAHA.108.119438","article-title":"Changes in serum potassium mediate thiazide-induced diabetes","volume":"52","author":"Shafi","year":"2008","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C519","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C520","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C521","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/HJH.0b013e328350e53b","article-title":"Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (Co-operation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea","volume":"30","author":"Parati","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C522","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/HYPERTENSIONAHA.106.085175","article-title":"Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea","volume":"50","author":"Bazzano","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C523","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00408-006-0117-x","article-title":"Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials","volume":"185","author":"Alajmi","year":"2007","journal-title":"Lung"},{"key":"2026080919364782900_EHT151C524","first-page":"1177","article-title":"[Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials]","volume":"87","author":"Mo","year":"2007","journal-title":"Zhonghua yi xue za zhi"},{"key":"2026080919364782900_EHT151C525","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archinte.167.8.757","article-title":"The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials","volume":"167","author":"Haentjens","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C526","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/HJH.0b013e32835bdcda","article-title":"Effects of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up","volume":"31","author":"Kasiakogias","year":"2013","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C527","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/jama.2012.4366","article-title":"Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial","volume":"307","author":"Barbe","year":"2012","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C528","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/jama.2012.3418","article-title":"Association between treated and untreated obstructive sleep apnea and risk of hypertension","volume":"307","author":"Marin","year":"2012","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C529","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/HJH.0b013e328351b988","article-title":"What should be learnt about the management of obstructive sleep apnea in hypertension?","volume":"30","author":"Zanchetti","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C530","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jama.1997.03540400043029","article-title":"End-stage renal disease in African-American and white men. 16-year MRFIT findings","volume":"277","author":"Klag","year":"1997","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C531","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2011.346","article-title":"Association between prehypertension and chronic kidney disease in the Japanese general population","volume":"81","author":"Yano","year":"2012","journal-title":"Kidney Int"},{"key":"2026080919364782900_EHT151C532","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C533","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(09)60212-9","article-title":"Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials","volume":"373","author":"Heerspink","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C534","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.165.8.947","article-title":"The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension","volume":"165","author":"Lea","year":"2005","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C535","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C536","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","article-title":"Changes in albuminuria predict mortality and morbidity in patients with vascular disease","volume":"22","author":"Schmieder","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026080919364782900_EHT151C537","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","article-title":"Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease","volume":"148","author":"Kunz","year":"2008","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C538","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/HJH.0b013e32834069bd","article-title":"Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial","volume":"29","author":"Ruggenenti","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C539","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","article-title":"Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of randomised controlled trial","volume":"375","author":"Bakris","year":"2010","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C540","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jhh.2011.60","article-title":"Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease","volume":"26","author":"Pisoni","year":"2012","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C541","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ki.2009.469","article-title":"Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"77","author":"Levin","year":"2010","journal-title":"Kidney Int"},{"key":"2026080919364782900_EHT151C542","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1474-4422(08)70263-1","article-title":"Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial","volume":"8","author":"Potter","year":"2009","journal-title":"Lancet Neurology"},{"key":"2026080919364782900_EHT151C543","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C544","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C545","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/2040622312450183","article-title":"Blood Pressure Lowering in Acute Phase of Stroke, Latest Evidence and Clinical Implication","volume":"3","author":"Fuentes Patarroyo","year":"2012","journal-title":"Ther Adv Chronic Dis"},{"key":"2026080919364782900_EHT151C546","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.STR.28.12.2557","article-title":"Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators","volume":"28","author":"Gueyffier","year":"1997","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C547","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C548","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/HJH.0b013e328306ebe2","article-title":"Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis","volume":"26","author":"Reboldi","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C549","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/HYPERTENSIONAHA.110.163055","article-title":"Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study","volume":"58","author":"Ninomiya","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C550","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurology"},{"key":"2026080919364782900_EHT151C551","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/STROKEAHA.108.540633","article-title":"Severe cerebral white matter hypersensities predict severe cognitive decline in patients with cerebrovascular disease history","volume":"40","author":"Dufouil","year":"2009","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C552","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.110.961052","article-title":"Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study","volume":"123","author":"Godin","year":"2011","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C553","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C554","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Prospective Study Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C555","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0895-7061(99)00042-4","article-title":"Effects of the administration of an angiotensin converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long Term Evaluation","volume":"12","author":"Borghi","year":"1999","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C556","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/euhj.1997.0822","article-title":"Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension","volume":"4","author":"Gustafsson","year":"1998","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C557","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/HJH.0b013e3282fe1d3d","article-title":"Development of heart failure in recent hypertension trials","volume":"26","author":"Tocci","year":"2008","journal-title":"J. Hypertens"},{"key":"2026080919364782900_EHT151C558","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Telmisartan Randomized Assessment Study in ACE intolerant subjects with cardiovascular disease (TRANSCEND) Investigators","year":"2008","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C559","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/hrt.2007.134973","article-title":"Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure","volume":"95","author":"Raphael","year":"2009","journal-title":"Heart"},{"key":"2026080919364782900_EHT151C560","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C561","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C562","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/HYPERTENSIONAHA.111.179713","article-title":"Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study","volume":"59","author":"Grundvold","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C563","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/HJH.0b013e32834f03bf","article-title":"Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension","volume":"30","author":"Manolis","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C564","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C565","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C566","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/STROKEAHA.112.651448","article-title":"Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial","volume":"43","author":"Arima","year":"2012","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C567","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared with atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C568","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C569","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C570","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C571","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"key":"2026080919364782900_EHT151C572","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1008816","article-title":"The Active\u200a I Investigators. Irbesartan in patients with atrial fibrillation","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C573","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2006.08.086","article-title":"Candesartan in the prevention of relapsing atrial fibrillation","volume":"120","author":"Tveit","year":"2007","journal-title":"Int J Cardiol"},{"key":"2026080919364782900_EHT151C574","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","article-title":"The GISSI-AF Investigators. Valsartan for prevention of recurrent atrial fibrillation","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C575","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.111.965178","article-title":"Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial","volume":"5","author":"Goette","year":"2012","journal-title":"Circulation Arrhythmia and Electrophysiology"},{"key":"2026080919364782900_EHT151C576","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin-angiotensin system inhibition: a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C577","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/eurheartj\/ehl484","article-title":"Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis","volume":"28","author":"Nasr","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C578","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"EMPHASIS-HF Study Investigators. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C579","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-152-2-201001190-00005","article-title":"Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study","volume":"152","author":"Schaer","year":"2010","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C580","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.109.136655","article-title":"Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies","volume":"54","author":"Fagard","year":"2009","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C581","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.STR.0000147041.00840.59","article-title":"Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS: a randomized double-blind trial","volume":"35","author":"Zanchetti","year":"2004","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C582","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/HJH.0b013e328346a583","article-title":"Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients","volume":"29","author":"Ong","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C583","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2011.12.005","article-title":"Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials","volume":"221","author":"Shahin","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026080919364782900_EHT151C584","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/HYPERTENSIONAHA.108.111674","article-title":"Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering","volume":"51","author":"Karalliedde","year":"2008","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C585","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1097\/HJH.0b013e32833da2b2","article-title":"Long-term reduction in aortic stiffness: a 5.3 year follow-up in routine clinical practice","volume":"28","author":"Ait Oufella","year":"2010","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C586","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.103.7.987","article-title":"Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure","volume":"103","author":"Guerin","year":"2001","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C587","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejvs.2008.01.007","article-title":"Management of hypertension in peripheral arterial disease: does the choice of drugs matter?","volume":"35","author":"Singer","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026080919364782900_EHT151C588","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"The Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C589","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejvs.2009.02.019","article-title":"Beta blockers for peripheral arterial disease","volume":"38","author":"Paravastu","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026080919364782900_EHT151C590","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.1991.00400090063012","article-title":"Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials","volume":"151","author":"Radack","year":"1991","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C591","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2011.06.024","article-title":"Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies","volume":"58","author":"Dong","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C592","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinternmed.2011.440","article-title":"The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis","volume":"171","author":"Gupta","year":"2011","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C593","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/HJH.0b013e32830dd0c6","article-title":"Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications","volume":"26","author":"Manolis","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C594","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.amjhyper.2004.07.004","article-title":"Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial","volume":"17","author":"Pickering","year":"2004","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C595","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjcard.2007.03.045","article-title":"Effect of treating erectile dysfunction on management of systolic hypertension","volume":"100","author":"Scranton","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026080919364782900_EHT151C596","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/HJH.0b013e32834e1e2e","article-title":"Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension","volume":"30","author":"Ma","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C597","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/heartjnl-2011-300741","article-title":"Resistant hypertension","volume":"98","author":"Fagard","year":"2012","journal-title":"Heart"},{"key":"2026080919364782900_EHT151C598","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"De la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C599","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C600","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003\u20132008","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C601","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2007-970409","article-title":"Detecting and treating primary aldosteronism: primary aldosteronism","volume":"115","author":"Mantero","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026080919364782900_EHT151C602","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.HYP.31.2.712","article-title":"Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study","volume":"31","author":"Redon","year":"1998","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C603","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/archinte.1991.00400090078014","article-title":"Resistant hypertension in a tertiary care clinic","volume":"151","author":"Yakovlevitch","year":"1991","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C604","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/HJH.0b013e3280d9434e","article-title":"Aldosterone antagonist therapy in resistant hypertension","volume":"25","author":"Zannad","year":"2007","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C605","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/HJH.0b013e328014954d","article-title":"Low-dose spironolactone in the management of resistant hypertension: a surveillance study","volume":"25","author":"Lane","year":"2007","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C606","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Vaclavik","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C607","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.107.737957","article-title":"Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial","volume":"118","author":"Chapman","year":"2008","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C608","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/HJH.0b013e3283551e98","article-title":"Sequential nephron blockade vs. sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study","volume":"30","author":"Bobrie","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C609","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Characterization of resistant hypertension: association between resistant hypertension, aldosterone and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C610","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/0002-9149(82)90390-3","article-title":"Increase in plasma aldosterone during prolonged captopril treatment","volume":"49","author":"Lijnen","year":"1982","journal-title":"Am J Cardiol"},{"key":"2026080919364782900_EHT151C611","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(09)61500-2","article-title":"A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Weber","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C612","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/HYPERTENSIONAHA.110.156976","article-title":"Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial","volume":"56","author":"Bakris","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C613","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(12)60825-3","article-title":"New drugs procedures and devices for hypertension","volume":"380","author":"Laurent","year":"2012","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C614","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","article-title":"Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial","volume":"58","author":"Bisognano","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C615","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jash.2012.01.003","article-title":"Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial","volume":"6","author":"Bakris","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"2026080919364782900_EHT151C616","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","article-title":"Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim Neo trial","volume":"6","author":"Hoppe","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"2026080919364782900_EHT151C617","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C618","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Simplicity HTN-1 Investigators Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months","volume":"57","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C619","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Simplicity HTN-Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","year":"2010","journal-title":"Lancet"},{"issue":"13s1","key":"2026080919364782900_EHT151C620","article-title":"Long-term follow up of catheter-based renal sympathetic denervation for resistant hypertension confirms durable blood pressure reduction","volume":"59","author":"Krum","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C621","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2012.07.029","article-title":"Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension","volume":"60","author":"Geisler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C622","first-page":"75","article-title":"Regional norepinephrine turnover in human hypertension","volume":"11","author":"Esler","year":"1989","journal-title":"Clin Exp Hypertens"},{"key":"2026080919364782900_EHT151C623","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.HYP.31.1.68","article-title":"Baroreflex Control of sympathetic nerve activity in essential and secondary hypertension","volume":"31","author":"Grassi","year":"1998","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C624","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.36.4.538","article-title":"Adrenergic and reflex abnormalities in obesity-related hypertension","volume":"36","author":"Grassi","year":"2000","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C625","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.1991.71.3.659","article-title":"Functional role of renal afferents","volume":"71","author":"Stella","year":"1991","journal-title":"Physiol Rev"},{"key":"2026080919364782900_EHT151C626","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function","volume":"77","author":"DiBona","year":"1997","journal-title":"Physiol Rev"},{"key":"2026080919364782900_EHT151C627","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/HJH.0b013e328352c3c7","article-title":"Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension:a perspective","volume":"30","author":"Doumas","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C628","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C629","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C630","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal haemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension","volume":"60","author":"Mahfoud","year":"2012","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C631","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJH.0b013e328352ce78","article-title":"ESH position paper: renal denervation: an interventional therapy of resistant hypertension","volume":"30","author":"Schmieder","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C632","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/STROKEAHA.108.518670","article-title":"Temporary reduction of blood pressure and sympathetic nerve activity in hypertensive patients after microvascular decompression","volume":"40","author":"Frank","year":"2009","journal-title":"Stroke"},{"key":"2026080919364782900_EHT151C633","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1097\/HJH.0b013e3283582eec","article-title":"Higher cardiovascular risk and impaired benefit of antihypertensve treatment in hypertensive patients requiring additional drugs on top of randomized therapy: is adding drugs always beneficial?","volume":"30","author":"Zhang","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C634","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/HJH.0b013e3283582ed6","article-title":"Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy","volume":"30","author":"Weber","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C635","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ajh.2009.153","article-title":"Improving survival of malignant hypertension patients over 40 years","volume":"22","author":"Lane","year":"2009","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C636","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/HJH.0b013e3283430b12","article-title":"Impact of malignant arterial hypertension on the heart","volume":"29","author":"Gosse","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C637","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/ndt\/gfq143","article-title":"Long-term renal survival in malignant hypertension","volume":"25","author":"Gonzalez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026080919364782900_EHT151C638","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004872-200501000-00005","article-title":"Is there a strong rationale for deferring elective surgery in patients with poorly controlled hypertension?","volume":"23","author":"Casadei","year":"2005","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C639","first-page":"2","article-title":"Perioperative screening and management of hypertensive patients","volume":"11","author":"Manolis","year":"2010","journal-title":"European Society of Hypertension Scientific Newsletter"},{"key":"2026080919364782900_EHT151C640","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jvs.2006.07.031","article-title":"Progression of atherosclerotic renovascular disease: A prospective population-based study","volume":"44","author":"Pearce","year":"2006","journal-title":"J Vasc Surg"},{"key":"2026080919364782900_EHT151C641","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM200102083440607","article-title":"Renal-artery stenosis","volume":"344","author":"Safian","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C642","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1191\/1358863x02vm456oa","article-title":"Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure","volume":"7","author":"Gray","year":"2002","journal-title":"Vasc Med"},{"key":"2026080919364782900_EHT151C643","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","article-title":"Revascularization vs. medical therapy for renal-artery stenosis","volume":"361","author":"Wheatley","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C644","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080919364782900_EHT151C645","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C646","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C647","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C648","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C649","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial: Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C650","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"The antihypertensive and lipid lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","author":"ALLHAT officers and co-ordinators for the ALLHAT collaborative research group","year":"2002","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C651","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/HJH.0b013e328326cb1a","article-title":"ASCOT Investigators. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension","volume":"27","author":"Sever","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C652","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C653","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C654","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C655","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"Stroke Prevention by aggressive reduction in cholesterol levels (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C656","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C657","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C658","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial","volume":"56","author":"Jardine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C659","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C660","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C661","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/db10-0296","article-title":"DCCT\/EDIC Research Group.Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"60","author":"Polak","year":"2011","journal-title":"Diabetes"},{"key":"2026080919364782900_EHT151C662","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"UK Prospective Diabetes Study (UKPDS ) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C663","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"UK Prospective Diabetes Study (UKPDS) GroupEffect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C664","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"ADVANCE Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C665","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C666","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C667","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C668","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"2026080919364782900_EHT151C669","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6898","article-title":"Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"343","author":"Hemmingsen","year":"2011","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C670","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centreed approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"2026080919364782900_EHT151C671","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrendo.2011.243","article-title":"SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects","volume":"8","author":"Ferrannini","year":"2012","journal-title":"Nature Rev Endocrinol"},{"key":"2026080919364782900_EHT151C672","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC\/EASD Guidelines on diabetes, pre-diabetes and cardiovascular diseases","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919364782900_EHT151C673","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bmj.37967.374063.EE","article-title":"Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners","volume":"328","author":"Birtwhistle","year":"2004","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C674","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c3995","article-title":"Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis","volume":"341","author":"Clark","year":"2010","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C675","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/HYPERTENSIONAHA.109.149336","article-title":"Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study","volume":"55","author":"Niiranen","year":"2010","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C676","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/07853890.2010.489567","article-title":"Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials","volume":"42","author":"Bray","year":"2010","journal-title":"Ann Med"},{"key":"2026080919364782900_EHT151C677","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(10)60964-6","article-title":"Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial","volume":"376","author":"McManus","year":"2010","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C678","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/hr.2010.91","article-title":"Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile","volume":"33","author":"Gupta","year":"2010","journal-title":"Hypertens Res"},{"key":"2026080919364782900_EHT151C679","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2011.250","article-title":"Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis","volume":"305","author":"Thompson","year":"2011","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C680","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C681","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3122\/jabfm.2011.01.100206","article-title":"Do physicians tell patients they have prehypertension?","volume":"24","author":"Viera","year":"2011","journal-title":"J Am Board Family Med"},{"key":"2026080919364782900_EHT151C682","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jash.2009.03.001","article-title":"A narrative review of clinical inertia: focus on hypertension","volume":"3","author":"Faria","year":"2009","journal-title":"J Am Soc Hypert"},{"key":"2026080919364782900_EHT151C683","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","article-title":"Worldwide prevalence of hypertension: a systematic review","volume":"22","author":"Kearney","year":"2004","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C684","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.107.087320","article-title":"Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients","volume":"49","author":"Muiesan","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C685","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurjhf\/hfq224","article-title":"Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study","volume":"13","author":"Okin","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080919364782900_EHT151C686","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.HYP.0000254322.96189.85","article-title":"Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial","volume":"49","author":"Gerdts","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C687","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.hjh.0000217862.50735.dc","article-title":"Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study","volume":"24","author":"Olsen","year":"2006","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C688","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2004.10.019","article-title":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy","volume":"45","author":"Atkins","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2026080919364782900_EHT151C689","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.jacc.2010.05.059","article-title":"Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials","volume":"56","author":"Costanzo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919364782900_EHT151C690","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ahj.2010.06.029","article-title":"Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis","volume":"160","author":"Goldberger","year":"2010","journal-title":"Am Heart J"},{"key":"2026080919364782900_EHT151C691","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(12)60441-3","article-title":"Carotid intima-media tickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individuial participant data","volume":"379","author":"Lorenz","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C692","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1097\/HJH.0b013e32835644dc","article-title":"Rate of exchange in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view","volume":"30","author":"Bots","year":"2012","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C693","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.HYP.26.1.60","article-title":"Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991","volume":"26","author":"Burt","year":"1995","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C694","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.atherosclerosis.2010.09.014","article-title":"Physicians' perception. knowledge and awareness of cardiovacsulr risk factors and adherence to prevention guidelines: the PERCRO-DOC survey","volume":"213","author":"Reiner","year":"2010","journal-title":"Atherosclerosis"},{"key":"2026080919364782900_EHT151C695","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/00004872-200306000-00021","article-title":"Why is hypertension so frequently uncontrolled in secondary prevention?","volume":"21","author":"Amar","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C696","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/01.hjh.0000175932.78774.32","article-title":"Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study","volume":"23","author":"Mancia","year":"2005","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C697","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/00004872-200309000-00011","article-title":"Why cardiovascular mortality is higher in treated hypertensives vs. subjects of the same age, in the general population","volume":"21","author":"Benetos","year":"2003","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C698","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.HYP.0000259104.60878.43","article-title":"Differences in blood pressure control and stroke mortality across Spain: the Prevencion de Riesgo de Ictus (PREV-ICTUS) study","volume":"49","author":"Redon","year":"2007","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C699","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","article-title":"Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II and III surveys in eight European countries","volume":"373","author":"Kotseva","year":"2009","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C700","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C701","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1586\/erc.09.102","article-title":"INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study","volume":"7","author":"Cooper-DeHoff","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026080919364782900_EHT151C702","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(02)11403-6","article-title":"Selected major risk factors and global and regional burden of disease","volume":"360","author":"Ezzati","year":"2002","journal-title":"Lancet"},{"key":"2026080919364782900_EHT151C703","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.HYP.0000127424.59774.84","article-title":"Blood pressure control and physician management of hypertension in hospital hypertension units in Spain","volume":"43","author":"Banegas","year":"2004","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C704","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/HJH.0b013e3282f4edd7","article-title":"Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy","volume":"26","author":"Corrao","year":"2008","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C705","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.296.21.joc60162","article-title":"Effect of a pharmacy care program on medication adherence and persistence, blood pressure and low-density lipoprotein cholesterol: a randomized controlled trial","volume":"296","author":"Lee","year":"2006","journal-title":"JAMA"},{"key":"2026080919364782900_EHT151C706","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2296-12-59","article-title":"Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study","volume":"12","author":"Gale","year":"2011","journal-title":"BMC Family Practice"},{"key":"2026080919364782900_EHT151C707","first-page":"98","volume-title":"Hypertension","author":"Shanti","year":"2003"},{"key":"2026080919364782900_EHT151C708","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.111.176859","article-title":"Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults","volume":"58","author":"Krousel-Wood","year":"2011","journal-title":"Hypertension"},{"key":"2026080919364782900_EHT151C709","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/HJH.0b013e328342ca97","article-title":"Better compliance to antihypertensive medications reduces cardiovascular risk","volume":"29","author":"Corrao","year":"2011","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C710","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","article-title":"Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients","volume":"120","author":"Mazzaglia","year":"2009","journal-title":"Circulation"},{"key":"2026080919364782900_EHT151C711","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C712","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/HJH.0b013e32833b4953","article-title":"Factors associated with therapeutic inertia in hypertension: validation of a predictive model","volume":"28","author":"Redon","year":"2010","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C713","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/HJR.0b013e328330be62","article-title":"Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial","volume":"17","author":"Luders","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026080919364782900_EHT151C714","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1751-7176.2010.00271.x","article-title":"Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study","volume":"12","author":"De Rivas","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026080919364782900_EHT151C715","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bmj.39259.400069.AD","article-title":"Tackling therapeutic inertia: role of treatment data in quality indicators","volume":"335","author":"Guthrie","year":"2007","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C716","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"2026080919364782900_EHT151C717","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2030","article-title":"Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework","volume":"337","author":"Ashworth","year":"2008","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C718","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d108","article-title":"Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study","volume":"342","author":"Serumaga","year":"2011","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C719","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1056\/NEJMsa0807651","article-title":"Effects of pay for performance on the quality of primary care in England","volume":"361","author":"Campbell","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919364782900_EHT151C720","first-page":"875","article-title":"Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review","volume":"55","author":"Fahey","year":"2005","journal-title":"Br J Gen Pract"},{"key":"2026080919364782900_EHT151C721","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bmj.325.7370.925","article-title":"Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports","volume":"325","author":"Weingarten","year":"2002","journal-title":"BMJ"},{"key":"2026080919364782900_EHT151C722","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1751-7176.2011.00542.x","article-title":"The hypertension team: the role of the pharmacist, nurse and teamwork in hypertension therapy","volume":"14","author":"Carter","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026080919364782900_EHT151C723","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-143-6-200509200-00007","article-title":"Meta-analysis: chronic disease self-management programs for older adults","volume":"143","author":"Chodosh","year":"2005","journal-title":"Ann Intern Med"},{"key":"2026080919364782900_EHT151C724","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/archinternmed.2009.316","article-title":"The potency of team-based care interventions for hypertension: a meta-analysis","volume":"169","author":"Carter","year":"2009","journal-title":"Arch Intern Med"},{"key":"2026080919364782900_EHT151C725","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.mlr.0000220260.30768.32","article-title":"Quality improvement strategies for hypertension management: a systematic review","volume":"44","author":"Walsh","year":"2006","journal-title":"Med Care"},{"key":"2026080919364782900_EHT151C726","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005182.pub4","article-title":"Interventions used to improve control of blood pressure in patients with hypertension","author":"Glynn","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919364782900_EHT151C727","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1345\/aph.1K311","article-title":"Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management","volume":"41","author":"Machado","year":"2007","journal-title":"Ann Pharmacother"},{"key":"2026080919364782900_EHT151C728","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1109\/TITB.2011.2176498","article-title":"Design and evaluation of a telemonitoring concept based on NFC-enabled mobile phones and sensor devices","volume":"16","author":"Morak","year":"2012","journal-title":"IEEE transactions on information technology in biomedicine: a publication of the IEEE Engineering in Medicine and Biology Society"},{"key":"2026080919364782900_EHT151C729","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0025-6196(11)62954-6","article-title":"Inferred blood pressure control with a physician-nurse team and home BP measurement","volume":"80","author":"Canzanello","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"2026080919364782900_EHT151C730","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/HJH.0b013e32833d1e01","article-title":"Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension","volume":"28","author":"Stergiou","year":"2010","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C731","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1741-6787.2012.00242.x","article-title":"Telehomecare communication and self-care in chronic conditions: moving toward a shared understanding","volume":"9","author":"Shea","year":"2012","journal-title":"Worldviews on evidence-based nursing \/ Sigma Theta Tau International, Honor Society of Nursing"},{"key":"2026080919364782900_EHT151C732","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/HJH.0b013e3283163caf","article-title":"Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study","volume":"27","author":"Parati","year":"2009","journal-title":"J Hypertens"},{"key":"2026080919364782900_EHT151C733","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/jhh.2010.119","article-title":"Blood pressure telemonitoring is useful to achieve blood pressure control in inadequately treated patients with arterial hypertension","volume":"25","author":"Neumann","year":"2011","journal-title":"J Hum Hypertens"},{"key":"2026080919364782900_EHT151C734","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ajh.2011.100","article-title":"Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies","volume":"24","author":"Omboni","year":"2011","journal-title":"Am J Hypertens"},{"key":"2026080919364782900_EHT151C735","doi-asserted-by":"crossref","DOI":"10.5334\/ijic.303","article-title":"Service developments for managing people with long-term conditions using case management approaches, an example from the UK","volume":"9","author":"Russell","year":"2009","journal-title":"International J Integrated Care"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/34\/28\/2159\/70579337\/eurheartj_34_28_2159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/34\/28\/2159\/70579337\/eurheartj_34_28_2159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:38:55Z","timestamp":1786318735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/34\/28\/2159\/451304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,14]]},"references-count":735,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2013,6,14]]},"published-print":{"date-parts":[[2013,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/eht151","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,7,21]]},"published":{"date-parts":[[2013,6,14]]}}}